Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 143K 128K 117K 107K 200K 13.57M 204K 1.4M 566K 7.16M 538K 527K 22.63M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.49M 18.8M 17.1M 32.06M 2.17B 32.7M 225M 90.52M 1.15B 86.13M 84.29M 3.62B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 2004-04-15 | |
| Chief Tech/Sci/R&D Officer | 61 | 2006-04-02 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 2006-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 1991-12-31 | |
Jeffrey Peterson
CHM | Chairman | 70 | 2012-08-07 |
Michael Urdea
BRD | Director/Board Member | 73 | 2013-02-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.06% | -0.33% | +20.31% | +52.52% | 258B | |
| -1.83% | -2.15% | +5.85% | +18.13% | 163B | |
| +1.12% | -3.27% | -18.23% | +57.21% | 150B | |
| +5.57% | -2.76% | -56.00% | -15.61% | 60.84B | |
| +1.19% | +2.62% | -10.64% | -8.42% | 53.31B | |
| +1.36% | +2.98% | +13.11% | +42.32% | 53.03B | |
| -1.90% | -3.51% | +5.43% | +61.66% | 50.67B | |
| -1.65% | -2.26% | +17.51% | +64.63% | 49.3B | |
| -2.85% | -1.41% | +28.58% | +83.18% | 45.46B | |
| Average | -0.12% | -1.09% | +0.66% | +39.51% | 98.22B | |
| Weighted average by Cap. | -0.56% | -1.28% | +2.97% | +40.76% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.54M 1.42M 1.29M 2.42M 164M 2.46M 16.92M 6.82M 86.41M 6.49M 6.35M 273M | 1.98M 1.77M 1.62M 1.47M 2.76M 187M 2.82M 19.35M 7.8M 98.83M 7.42M 7.26M 312M |
| Net income | -16.08M -14.35M -13.17M -11.98M -22.46M -1.52B -22.91M -157M -63.41M -803M -60.34M -59.05M -2.54B | -29.31M -26.17M -24.02M -21.85M -40.96M -2.78B -41.78M -287M -116M -1.46B -110M -108M -4.63B |
| Net Debt | 20.53M 18.33M 16.82M 15.3M 28.68M 1.94B 29.25M 201M 80.96M 1.03B 77.04M 75.39M 3.24B | 22.8M 20.36M 18.68M 17M 31.86M 2.16B 32.5M 223M 89.95M 1.14B 85.59M 83.76M 3.6B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
